Citations (87)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (24)
Alberto Aparicio. (2022) The road ahead: narratives and imaginaries of the value of biodiversity in shaping bioeconomy policy in Colombia. Tapuya: Latin American Science, Technology and Society 5:1.
Read now
Read now
Bradley Lonergan, Richard A. Williams, Takuya Matsushige & Laura L. Machin. (2022) Exploring “quality” in cord blood transfusion: uncertainties, bionetworks, and collaborations. New Genetics and Society 41:2, pages 136-156.
Read now
Read now
Sophie Day, William Viney, Jane Bruton & Helen Ward. (2021) Past-futures in experimental care: breast cancer and HIV medicine. New Genetics and Society 40:4, pages 449-472.
Read now
Read now
Céline Lafontaine, Maxime Wolfe, Janie Gagné & Elisabeth Abergel. (2021) Bioprinting as a Sociotechnical Project: Imaginaries, Promises and Futures. Science as Culture 30:4, pages 556-580.
Read now
Read now
Charlotte Kroløkke & Anna Sofie Bach. (2020) Putting menopause on ice: the cryomedicalization of reproductive aging. New Genetics and Society 39:3, pages 288-305.
Read now
Read now
Lorenzo Beltrame. (2020) Anchoring hopes in a regime of truth. The legitimizing use of cord blood-derived products in Italy. New Genetics and Society 39:2, pages 173-190.
Read now
Read now
Carmen McLeod, Brigitte Nerlich & Rusi Jaspal. (2019) Fecal microbiota transplants: emerging social representations in the English-language print media. New Genetics and Society 38:3, pages 331-351.
Read now
Read now
Suli Sui & Margaret Sleeboom-Faulkner. (2019) Hybrid UCB banks in China – public storage as ethical biocapital. New Genetics and Society 38:1, pages 60-79.
Read now
Read now
Rosalind Williams. (2018) Bloody infrastructures!: Exploring challenges in cord blood collection maintenance. Technology Analysis & Strategic Management 30:4, pages 473-483.
Read now
Read now
Rosalind Williams. (2018) Enactments of Race in the UK’s Blood Stem Cell Inventory. Science as Culture 27:1, pages 24-43.
Read now
Read now
Richard Milne. (2016) In search of lost time: age and the promise of induced pluripotent stem cell models of the brain. New Genetics and Society 35:4, pages 393-408.
Read now
Read now
Margaret Sleeboom-Faulkener & Hung-Chieh Chang. (2016) The private, the public and the hybrid in umbilical cord blood banking – a global perspective. New Genetics and Society 35:3, pages 223-227.
Read now
Read now
Yeonbo Jeong. (2016) Contested expectations: the cord blood economy in South Korea. New Genetics and Society 35:3, pages 289-306.
Read now
Read now
Hung-Chieh Chang. (2016) The multiple roles of cord blood banks in Taiwan: competition and collaboration. New Genetics and Society 35:3, pages 246-266.
Read now
Read now
Christine Hauskeller & Lorenzo Beltrame. (2016) Hybrid practices in cord blood banking. Rethinking the commodification of human tissues in the bioeconomy. New Genetics and Society 35:3, pages 228-245.
Read now
Read now
Alan Petersen, Casimir MacGregor & Megan Munsie. (2016) Stem cell miracles or Russian roulette?: patients’ use of digital media to campaign for access to clinically unproven treatments. Health, Risk & Society 17:7-8, pages 592-604.
Read now
Read now
Ros Williams. (2015) Cords of collaboration: interests and ethnicity in the UK's public stem cell inventory. New Genetics and Society 34:3, pages 319-337.
Read now
Read now
Maria Fannin & Julie Kent. (2015) Origin stories from a regional placenta tissue collection. New Genetics and Society 34:1, pages 25-51.
Read now
Read now
Yeonbo Jeong. (2014) Scientific motherhood, responsibility, and hope: umbilical cord blood banking in South Korea. New Genetics and Society 33:4, pages 349-369.
Read now
Read now
Pei P. Koay & Richard R. Sharp. (2014) Managing expectational language: translational genetic professionals consider the clinical potential of next-generation sequencing technologies. New Genetics and Society 33:2, pages 126-148.
Read now
Read now
John Abraham & Rachel Ballinger. (2012) The emergence of the genetically engineered animal models in carcinogenic risk assessment of pharmaceuticals: a case study of process innovation. New Genetics and Society 31:2, pages 223-247.
Read now
Read now
Alan Petersen & Kate Seear. (2011) Technologies of hope: techniques of the online advertising of stem cell treatments. New Genetics and Society 30:4, pages 329-346.
Read now
Read now
Haidan Chen. (2011) Cord-Blood Banking in China: Public and Private Tensions. East Asian Science, Technology and Society: An International Journal 5:3, pages 329-339.
Read now
Read now
Maria Fannin. (2011) Personal stem cell banking and the problem with property. Social & Cultural Geography 12:4, pages 339-356.
Read now
Read now
Articles from other publishers (63)
Ruzana Liburkina. (2022) Cryovalues beyond High Expectations: Endurance and the Construction of Value in Cord Blood Banking. Science, Technology, & Human Values 48:4, pages 777-804.
Crossref
Crossref
Pauline McCormack. (2023) From embodiment to evidence: The harmful intersection of poor regulation of medical implants and obstructed narratives in embodied experiences of failed metal-on-metal hips. Health: An Interdisciplinary Journal for the Social Study of Health, Illness and Medicine, pages 136345932311790.
Crossref
Crossref
Anne-Floor J. de Kanter, Karin R. JongsmaMarianne C. VerhaarAnnelien L. Bredenoord. (2023) The Ethical Implications of Tissue Engineering for Regenerative Purposes: A Systematic Review. Tissue Engineering Part B: Reviews 29:2, pages 167-187.
Crossref
Crossref
Neda Saraygord-Afshari, Sonia Ghayem, Reza Foudazi & Majid Safa. (2022) Drivers of consumers’ behavioral intention toward private umbilical cord blood banking: a review. Cell and Tissue Banking.
Crossref
Crossref
Xuanxuan Tan. (2022) Hope and trust: Public attitudes toward mass COVID-19 testing programs in Guangzhou, China. Frontiers in Psychology 13.
Crossref
Crossref
Vladimír Baláž, Tomáš Jeck & Miroslav Balog. (2022) Economics of Biobanking: Business or Public Good? Literature Review, Structural and Thematic Analysis. Social Sciences 11:7, pages 288.
Crossref
Crossref
Larry Au. (2020) Imagining the public: anticipatory discourses in China’s push for precision medicine. BioSocieties 17:1, pages 53-77.
Crossref
Crossref
Nolwenn Bühler & Cathy Herbrand. (2020) Powering life through MitoTechnologies: exploring the bio-objectification of mitochondria in reproduction. BioSocieties 17:1, pages 99-122.
Crossref
Crossref
Larry Au. (2021) Testing the talented child: Direct-to-consumer genetic talent tests in China. Public Understanding of Science 31:2, pages 195-210.
Crossref
Crossref
William Viney & Sophie Day. 2022. Figure. Figure
127
148
.
Alessandro R. Marcon, Blake Murdoch & Timothy Caulfield. (2021) Peddling promise? An analysis of private umbilical cord blood banking company websites in Canada. Cell and Tissue Banking 22:4, pages 609-622.
Crossref
Crossref
Emilia Sanabria. (2021) Vegetative value: promissory horizons of therapeutic innovation in the global circulation of ayahuasca. BioSocieties 16:3, pages 387-410.
Crossref
Crossref
Nolwenn Bühler. 2021. When Reproduction Meets Ageing. When Reproduction Meets Ageing
203
232
.
Richard Helliwell & Rob J.F. Burton. (2021) The promised land? Exploring the future visions and narrative silences of cellular agriculture in news and industry media. Journal of Rural Studies 84, pages 180-191.
Crossref
Crossref
Clémence Pinel. (2020) Renting Valuable Assets: Knowledge and Value Production in Academic Science. Science, Technology, & Human Values 46:2, pages 275-297.
Crossref
Crossref
Sonia Ghayem & Reza Foudazi. 2021. Progress in Intelligent Decision Science. Progress in Intelligent Decision Science
26
41
.
Blake Murdoch, Alessandro R Marcon & Timothy Caulfield. (2020) The law and problematic marketing by private umbilical cord blood banks. BMC Medical Ethics 21:1.
Crossref
Crossref
Zubin Master, Aidan P. Crowley, Cambray Smith, Dennis Wigle, Andre Terzic & Richard R. Sharp. (2020) Stem cell preservation for regenerative therapies: ethical and governance considerations for the health care sector. npj Regenerative Medicine 5:1.
Crossref
Crossref
Almudena Marí Sáez, Maya Ronse, Alexandre Delamou, Nyankoye Haba, Frédéric Bigey, Johan van Griensven & Koen Peeters Grietens. (2020) The Plasma Mobile, ‘A gift from heaven’: The impact of health technology transfer on trial perceptions and expectations during the Ebola-Tx Trial, Conakry. PLOS Neglected Tropical Diseases 14:4, pages e0008206.
Crossref
Crossref
Clémence Pinel, Barbara Prainsack & Christopher McKevitt. (2020) Caring for data: Value creation in a data-intensive research laboratory. Social Studies of Science 50:2, pages 175-197.
Crossref
Crossref
Alessandro R Marcon, David Allan, Morgan Barber, Blake Murdoch & Timothy Caulfield. (2020) Portrayal of umbilical cord blood research in the North American popular press: promise or hype?. Regenerative Medicine 15:1, pages 1228-1237.
Crossref
Crossref
Lorenzo Beltrame. (2019) ‘It’s a family affair’: The discursive entanglement of social formations in public and private cord blood banking in Italy. Public Understanding of Science 28:8, pages 917-931.
Crossref
Crossref
Martyn Pickersgill. (2018) Digitising psychiatry? Sociotechnical expectations, performative nominalism and biomedical virtue in (digital) psychiatric praxis. Sociology of Health & Illness 41:S1, pages 16-30.
Crossref
Crossref
Anouck Alary. (2019) La conservation familiale de sang placentaire et la (re)privatisation de la reproduction sociale Family-directed cord blood banking and the (re)privatization of social reproduction. Genre, sexualité et société:21.
Crossref
Crossref
Julie Kent & Darian Meacham. (2019) ‘Synthetic Blood’: Entangling Politics and Biology. Body & Society 25:2, pages 28-55.
Crossref
Crossref
Charlotte Kroløkke. (2019) Life in the cryo-kennel: The ‘exceptional’ life of frozen pet DNA. Social Studies of Science 49:2, pages 162-179.
Crossref
Crossref
Nik BrownNik Brown. 2019. Immunitary Life. Immunitary Life
47
88
.
. 2018. Personalised Medicine, Individual Choice and the Common Good. Personalised Medicine, Individual Choice and the Common Good.
Richard Milne. (2018) From people with dementia to people with data: Participation and value in Alzheimer’s disease research. BioSocieties 13:3, pages 623-639.
Crossref
Crossref
Cathy Herbrand & Rebecca Dimond. (2017) Mitochondrial donation, patient engagement and narratives of hope. Sociology of Health & Illness 40:4, pages 623-638.
Crossref
Crossref
Marina Marouda. (2017) Clinical trials and venture tribulations: Stem cell research and the making of Vietnamese bio-entrepreneurs. Critique of Anthropology 38:1, pages 96-114.
Crossref
Crossref
Shashank S. Tiwari. 2018. Emerging Markets from a Multidisciplinary Perspective. Emerging Markets from a Multidisciplinary Perspective
391
404
.
Shashank S Tiwari, Sujatha Raman & Paul Martin. (2017) Regenerative medicine in India: trends and challenges in innovation and regulation. Regenerative Medicine 12:7, pages 875-885.
Crossref
Crossref
Hung-Chieh Chang. (2017) The role of policies and networks in development of cord blood usage in China. Regenerative Medicine 12:6, pages 637-645.
Crossref
Crossref
Beth Kewell & Peter Michael Ward. (2017) Blockchain futures: With or without Bitcoin?. Strategic Change 26:5, pages 491-498.
Crossref
Crossref
Anna M. Agathangelou. (2017) Humanitarian Innovations and Material Returns: Valuation, Bio-financialisation and Radical Politics. Science, Technology and Society 22:1, pages 78-101.
Crossref
Crossref
Vincenzo Pavone. 2017. Bioeconomies. Bioeconomies
129
159
.
Pablo Santoro & Carmen Romero-Bachiller. 2017. Bioeconomies. Bioeconomies
279
302
.
Vincenzo Pavone & Joanna Goven. 2017. Bioeconomies. Bioeconomies
1
22
.
Christine Hauskeller & Lorenzo Beltrame. (2016) The hybrid bioeconomy of umbilical cord blood banking: Re-examining the narrative of opposition between public and private services. BioSocieties 11:4, pages 415-434.
Crossref
Crossref
Jennie Haw. (2016) Corporeal Commodification and Women’s Work. Body & Society 22:3, pages 31-53.
Crossref
Crossref
Markus Bugge, Teis Hansen & Antje Klitkou. (2016) What Is the Bioeconomy? A Review of the Literature. Sustainability 8:7, pages 691.
Crossref
Crossref
Alexandra Soulier & Anne Cambon-Thomsen. (2016) Promesses de biobanques : se soucier de l’avenir dans l’éthique de la recherche biomédicale. Revue française d'éthique appliquée N° 2:2, pages 29-47.
Crossref
Crossref
Paul Martin. (2015) Commercialising neurofutures: Promissory economies, value creation and the making of a new industry. BioSocieties 10:4, pages 422-443.
Crossref
Crossref
Joanna Goven & Vincenzo Pavone. (2014) The Bioeconomy as Political Project. Science, Technology, & Human Values 40:3, pages 302-337.
Crossref
Crossref
Rachel Haase, Marsha Michie & Debra Skinner. (2015) Flexible positions, managed hopes: The promissory bioeconomy of a whole genome sequencing cancer study. Social Science & Medicine 130, pages 146-153.
Crossref
Crossref
Alan Petersen & Ivan Krisjansen. (2015) Assembling ‘the bioeconomy’: Exploiting the power of the promissory life sciences. Journal of Sociology 51:1, pages 28-46.
Crossref
Crossref
Liliana Acero. (2015) Internacionalização, ciência e saúde: a medicina regenerativa global e os mercados paralelos. Ciência & Saúde Coletiva 20:2, pages 433-440.
Crossref
Crossref
Maria Mitrossili, Amalia Dinou, Vasiliki Gkioka & Catherine Stavropoulos-Giokas. 2015. Cord Blood Stem Cells and Regenerative Medicine. Cord Blood Stem Cells and Regenerative Medicine
249
260
.
Peter Glasner. 2015. International Encyclopedia of the Social & Behavioral Sciences. International Encyclopedia of the Social & Behavioral Sciences
975
983
.
Liliana Acero. (2014) Políticas internacionais em ciência e saúde: a pesquisa celular e a medicina regenerativa. Physis: Revista de Saúde Coletiva 24:3, pages 851-870.
Crossref
Crossref
Maria Fannin. (2013) The Hoarding Economy of Endometrial Stem Cell Storage. Body & Society 19:4, pages 32-60.
Crossref
Crossref
S. Ulucanlar, A. Faulkner, S. Peirce & G. Elwyn. (2013) Technology identity: The role of sociotechnical representations in the adoption of medical devices. Social Science & Medicine 98, pages 95-105.
Crossref
Crossref
Martyn Pickersgill. (2013) The social life of the brain: Neuroscience in society. Current Sociology 61:3, pages 322-340.
Crossref
Crossref
Sherri M. Broder, Roselle S. Ponsaran & Aaron J. Goldenberg. (2013) US public cord blood banking practices: recruitment, donation, and the timing of consent. Transfusion 53:3, pages 679-687.
Crossref
Crossref
Richard Milne. (2012) Pharmaceutical prospects: Biopharming and the geography of technological expectations. Social Studies of Science 42:2, pages 290-306.
Crossref
Crossref
Brigitte Nerlich. (2011) ‘Low carbon’ metals, markets and metaphors: the creation of economic expectations about climate change mitigation. Climatic Change 110:1-2, pages 31-51.
Crossref
Crossref
Nik Brown, Laura Machin & Danae McLeod. (2011) Immunitary bioeconomy: The economisation of life in the international cord blood market. Social Science & Medicine 72:7, pages 1115-1122.
Crossref
Crossref
Bruno Rodrigues Alves & Susana Silva. (2011) Questões científicas nos projetos de investigação em embriões realizados em PortugalScientific issues on embryo research in PortugalQuestions scientifiques dans la recherche sur l’embryon. Configurações:8, pages 57-72.
Crossref
Crossref
Liliana Acero. (2011) Governança na nova genética e a participação pública: o caso das pesquisas com células-tronco. Physis: Revista de Saúde Coletiva 21:3, pages 795-812.
Crossref
Crossref
Devyn Smith. (2010) Commercialization challenges associated with induced pluripotent stem cell-based products. Regenerative Medicine 5:4, pages 593-603.
Crossref
Crossref
Virginie Tournay, Marie-Odile Ott, Dörte Bemme & Christelle Routelous. (2011) La United Kingdom Stem Cell Bank. Sociologie et sociétés 42:2, pages 291-312.
Crossref
Crossref
Liliana Acero. (2010) Ciência, políticas públicas e inclusão social: debates sobre células-tronco no Brasil e no Reino Unido. Dados 53:4, pages 855-887.
Crossref
Crossref